# Biogenes technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biogenes-technologies

- Industry: Biotechnology
- Headquarters: Selangor, Malaysia
- Website: www.biogenestech.com
- Total disclosed funding: $5.7M
- Latest round: Series A (Jan 18, 2023)
- Investors on record: 1

## About

Based in Selangor, Malaysia, and founded in 2015, Biogenes Technologies Sdn. Bhd., a.k.a. Biogenes Technologies is a biotech company that develops, produces, and markets synthetic antibody diagnostics products through its proprietary platform for molecular diagnostics applications. In January 2023, Biogenes Technologies Sdn. Bhd. raised USD 5.7 million in a Series A funding from Bank Pembangunan Malaysia Berhad.

Biogenes Technologies develops aptamer-based diagnostics products from molecular diagnostics and genomics for a wide range of applications, such as human healthcare, animal health, agriculture, food safety, and environmental monitoring. The company also provides platform technologies that include printed nano-coated sensors, aptamers (synthetic antibodies), immobilization of DNA probes, validation of new aptamers, and in-silico design. In addition, the firm offers a mobile application that allows complete control of the APTSENS reader.

## Funding rounds

- Series A, Jan 18, 2023, $5.7M — Pembangunan Ekuiti Sdn. Bhd

## Investors

- Pembangunan Ekuiti Sdn. Bhd (https://capitalatlas.ai/funds/pembangunan-ekuiti-sdn-bhd) — Series A